Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth (Status and Outlook) 2025-2031

The global Circulating Tumor Cells (CTC) Liquid Biopsy market size is predicted to grow from US$ 1510 million in 2025 to US$ 3351 million in 2031; it is expected to grow at a CAGR of 14.2% from 2025 to 2031.

North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.

LPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTC) Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTC) Liquid Biopsy sales in 2024, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTC) Liquid Biopsy sales for 2025 through 2031. With Circulating Tumor Cells (CTC) Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTC) Liquid Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circulating Tumor Cells (CTC) Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTC) Liquid Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTC) Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTC) Liquid Biopsy.

This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy market by product type, application, key players and key regions and countries.

Segmentation by Type:

Kits & Reagents

Blood Collection Tubes

Devices

Segmentation by Application:

Research & Academic Institutes

Hospitals

Physician Laboratories

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

QIAGEN

Bio-Techne

Precision Medical

Aviva Systems Biological

Biocept

Fluxion Biosciences

Greiner Bio-One International GmbH

Ikonisys

Miltenyi Biotec

IVDiagnostics

BioFluidica

Canopus Medical

Biolidics

Creativ MicroTech

LungLife AI

Epic Sciences

Rarecells Diagnostics

ScreenCell

Menarini Silicon Biosystems

Please note: The report will take approximately 2 business days to prepare and deliver.